Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, China.
J Dig Dis. 2022 May;23(5-6):262-269. doi: 10.1111/1751-2980.13104. Epub 2022 Jul 19.
The aim of this study was to assess the level of satisfaction with currently prescribed medications for gastroesophageal reflux disease (GERD) in patients and physicians in China.
Physicians across China were invited to complete physician surveys concerning factors affecting the prescription of medication for GERD and their satisfaction through an online questionnaire. The enrolled physicians invited the first five GERD patients who visited them on the same day to complete online patient surveys concerning the satisfaction with medications for GERD and its influencing factors.
In total, 334 physician surveys (response rate 36.82%) and 1409 patient surveys (86.07%) were analyzed. Over half (62.57%) the physicians recommended taking a proton pump inhibitor (PPI) twice daily and the majority (88.02%) recommended taking a PPI for 1 week to 3 months. Factors affecting the prescription were how much it could improve quality of life (84.73%), followed by safety, medication compliance, and efficacy. Approximately 30% of patients reported taking a PPI twice daily and 47.20% reported taking a PPI for 1 week to 3 months. Factor affecting patients' adherence to medications was safety (64.30%), followed by medical insurance, efficacy and convenience. Approximately one-third of physicians and patients did not report "satisfied" or "very satisfied" with medications for GERD, including 10.51% of patients and 12.87% of physicians reporting "dissatisfied" or "very dissatisfied."
One-third of GERD patients and physicians were not satisfied or very satisfied with medications for GERD. Novel medications may help optimize the management of GERD.
本研究旨在评估中国患者和医生对胃食管反流病（GERD）目前处方药物的满意度水平。
中国各地的医生受邀通过在线问卷完成有关影响 GERD 药物处方的因素及其满意度的医生调查。参与的医生邀请当天就诊的前 5 位 GERD 患者完成在线患者调查，内容涉及 GERD 药物满意度及其影响因素。
共分析了 334 份医生调查（应答率为 36.82%）和 1409 份患者调查（86.07%）。超过一半（62.57%）的医生建议每天服用质子泵抑制剂（PPI）两次，大多数（88.02%）建议服用 PPI 1 至 3 个月。影响处方的因素是能在多大程度上提高生活质量（84.73%），其次是安全性、药物依从性和疗效。约 30%的患者报告每天服用 PPI 两次，47.20%的患者报告服用 PPI 1 至 3 个月。影响患者用药依从性的因素是安全性（64.30%），其次是医疗保险、疗效和便利性。约三分之一的医生和患者未报告对 GERD 药物“满意”或“非常满意”，其中 10.51%的患者和 12.87%的医生报告“不满意”或“非常不满意”。
三分之一的 GERD 患者和医生对 GERD 药物不满意或非常不满意。新型药物可能有助于优化 GERD 的管理。
